Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How CCUS technology integrates with industrial flue gas infrastructure: patent analysis covering pre-treatment, retrofit design, CO2 utilization, and leading innovators.
Article | Report Bistable mechanism technology in 2026: patent landscape, key innovators, MEMS, compliant structures, snap-through architectures, and emerging application domains.
Article | Report How to implement ISO 27001 cybersecurity controls in connected medical devices under FDA premarket guidance — covering proxy architectures, device provisioning, and threat modelling.
Article | Report A 2026 patent landscape of microrobotic capsule endoscopy: 28 years of innovation, 80+ records, AI navigation, electromagnetic actuation, and therapeutic payloads mapped.
Article | Report FXR agonists, PPAR modulators, RNAi, and CAR-Treg therapies are reshaping the PBC, AIH, and cholestatic liver disease pipeline. Explore the patent landscape.
Article | Report How does AI-powered visual inspection compare to traditional rule-based machine vision for surface defect classification? A patent-based technical analysis of 50+ filings.
Article | Report Mapping the 2026 PCFC patent landscape: BZCY electrolytes, leakage current barriers, hybrid architectures, and Japan's dominant IP position in proton ceramic fuel cells.
Article | Report A patent-driven analysis of magnetic shape memory alloy (MSMA) technology in 2026: key compositions, assignees, application domains, and emerging IP white spaces.
Article | Report How DIC improves strain measurement accuracy in fatigue testing of composite structures — full-field maps, error mitigation, crack detection, and aerospace applications.
Article | Report Mapping the MSMA patent landscape 2026: alloy compositions, actuator architectures, key assignees, and emerging directions across 30+ years of innovation.
Article | Report Analyse the CRC drug pipeline: VEGF/PD-1 combinations, KRAS G12C/G12D inhibitors, LAG-3, CD47/SIRPα blockade, and MEK triple-combination strategies shaping next-generation colorectal cancer therapy.
Article | Report An analysis of 80+ patents spanning 2000–2026 maps the haptic feedback actuator technology landscape: key clusters, assignees, application domains, and emerging directions.
Article | Report How to qualify ceramic matrix composite (CMC) components for commercial aero engine hot section replacement — design, testing, health monitoring, and repair frameworks.
Article | Report Menin inhibitors, MCL-1 inhibitors, and protein degrader approaches are reshaping the AML drug pipeline. Explore patent and literature signals from the emerging frontier.
Article | Report An 80+ patent analysis of haptic feedback actuator technology: key clusters, assignees, emerging directions, and strategic IP implications for 2026 and beyond.